Introduction: Lung cancer is a major cause of cancer-related deaths, with 2 million new cases annually. Bronchopulmonary neuroendocrine tumors (BP-NETs) comprise about 20 % of lung cancers, including typical carcinoid tumors (TC). While tobacco is a primary risk factor, non-tobacco factors also play a role. Typically, NETs affect individuals over 50, with typical carcinoids being rare in children. This report discusses a unique case of a typical carcinoid in a 10-year-old boy linked to environmental exposure.
Case Presentation: A 10-year-old boy presented with cough, dyspnea, hemoptysis, and recurrent pneumonia. Imaging revealed lobar collapse and a large mass in the right lower lobe. Surgical excision confirmed a carcinoid tumor with no lymph node metastasis. Post-surgery, the patient showed complete symptom resolution during follow-up.
Discussion: Neuroendocrine tumors (NETs) are uncommon in children and can present with respiratory symptoms. This case highlights the importance of considering NETs in pediatric patients, particularly with environmental exposure. Timely diagnosis and surgical intervention led to a successful outcome, emphasizing the need for awareness of these tumors in younger populations.
Conclusion: This case report presents a rare typical carcinoid tumor in a 10-year-old boy, with successful surgical resection leading to complete symptom resolution. It highlights the need to recognize bronchopulmonary neuroendocrine tumors in children, particularly those with environmental exposure, and underscores the importance of ongoing follow-up for affected patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijscr.2024.110811 | DOI Listing |
Int J Surg Case Rep
December 2024
University of Aleppo, Faculty of Medicine, Aleppo, Syria.
Introduction: Lung cancer is a major cause of cancer-related deaths, with 2 million new cases annually. Bronchopulmonary neuroendocrine tumors (BP-NETs) comprise about 20 % of lung cancers, including typical carcinoid tumors (TC). While tobacco is a primary risk factor, non-tobacco factors also play a role.
View Article and Find Full Text PDFJ Clin Sleep Med
December 2024
Université de Paris-Cité, AP-HP, Hôpital Robert Debré, Service de Physiologie Pédiatrique-Centre du Sommeil, INSERM NeuroDiderot, Paris, France.
This study presents two cases of central sleep apnea syndrome in children, highlighting the utility of assessing ventilatory control stability, particularly loop gain and central chemosensitivity in treatment decision-making. In the first case, elevated loop gain for oxygen correlated with periodic breathing, leading to successful treatment with supplemental oxygen in a 13 year-old boy with Prader-Willi-like syndrome. Conversely, in the second case, dealing with a 10 year-old girl with tumor in the brainstem-spinal cord junction, reduced loop gain prompted treatment with nocturnal non-invasive ventilation.
View Article and Find Full Text PDFIntroduction: Hereditary bleeding disorders stem from the absence or insufficient levels of particular clotting proteins, essential for facilitating coagulation in the clotting cascade. Among the most prevalent are hemophilia A (deficiency of Factor VIII), hemophilia B (deficiency of Factor IX), and von Willebrand disease. Management of pharmacoresistant epilepsy is more difficult in a patient with bleeding disorder due to increased risk of bleeding during surgery.
View Article and Find Full Text PDFPediatr Rev
January 2025
Department of Pediatric Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio.
Cureus
November 2024
Pediatrics, Child and Parents Support Clinic, Ebina, JPN.
Melatonin is commonly used to treat sleep disorders. Regardless of the prolactin level elevation induced by melatonin administration, breast budding is not known to develop as a result of this treatment. A 10-year-old boy presented to our outpatient clinic with restlessness and sleep disorders.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!